Patients With Severe Pulmonary Arterial Hypertension Treated With Abi-009, Nab-sirolimus, an Mtor Inhibitor: Interim Results From a Phase 1 Clinical Trial
Year: 2019
Type: article
Study design: Clinical Trial
Institution: University of Pittsburgh Medical Center
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W2918935564
